Dr Philippe Cassier is the head of the early trials unit and the head of the adult CLIP² (Centre Labellisé INCa de Phase Précoce) at the Léon Bérard Centre. He graduated in medical oncology from the Faculty of Medicine in Lyon and obtained a doctorate in science from the University Claude Bernard Lyon 1. His activity, essentially clinical, is focused on the development of targeted therapies and new combinations of immunotherapy for the treatment of patients with cancers, particularly of the digestive sphere.
